MGMT and central nervous system cancer: In addition, multiple Cox regression revealed grade, IDH mutations, 1p/19q codeletions, promoter methylation of MGMT, and PLK1 mRNA levels might be independent predictors of prognosis of glioma patients (Supplementary Figure 4A).